rq1 dnase Search Results


rq1 rnase-free dnase  (Novozymes limited)
90
Novozymes limited rq1 rnase-free dnase
Rq1 Rnase Free Dnase, supplied by Novozymes limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq1+rnase+free+dnase/pm40003041-90-12-19
Average 90 stars, based on 1 article reviews
rq1 rnase-free dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rnase-free dnase  (Promega)
90
Promega rnase-free dnase
Rnase Free Dnase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq1+rnase+free+dnase/pmc03857587-104-15-17
Average 90 stars, based on 1 article reviews
rnase-free dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
5 units of rq1 rnase-free dnase  (Promega)
90
Promega 5 units of rq1 rnase-free dnase
5 Units Of Rq1 Rnase Free Dnase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/1+unit+of+rq1+dnase/pmc01797217-170-15-18
Average 90 stars, based on 1 article reviews
5 units of rq1 rnase-free dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rq1-dnase treatment  (Promega)
90
Promega rq1-dnase treatment
Rq1 Dnase Treatment, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq1+dnase+buffer/pmc01885557-67-18-20
Average 90 stars, based on 1 article reviews
rq1-dnase treatment - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
5.5 ml rq1 rnase-free dnase i buffer  (Promega)
90
Promega 5.5 ml rq1 rnase-free dnase i buffer
5.5 Ml Rq1 Rnase Free Dnase I Buffer, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/1+ml+rq1+dnase/pm22329904-285-14-22
Average 90 stars, based on 1 article reviews
5.5 ml rq1 rnase-free dnase i buffer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rq1 dnase  (Promega)
90
Promega rq1 dnase
Rq1 Dnase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq1+dnase/us06953777-393-4-6
Average 90 stars, based on 1 article reviews
rq1 dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rq1 dnase i and impromii  (Promega)
90
Promega rq1 dnase i and impromii
Rq1 Dnase I And Impromii, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq1+dnase+i+and+impromii/pmc04528155-109-18-19
Average 90 stars, based on 1 article reviews
rq1 dnase i and impromii - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rq1 dnase i  (Promega)
90
Promega rq1 dnase i
Performance of the multiplex-assay on clinical trial samples. a , b Agreement with previously measured gametocyte densities with single assays, using <t>Pfs25</t> ( a ) and PfMGET ( b ) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 [0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] , y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] and for MG y = 0.8626 [0.7744–0.9507]x + 0.5919 [0.2802–0.9037] , y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] . c Gametocyte prevalence as determined by single or multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c
Rq1 Dnase I, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq1+dnase+i/pmc06267050-76-29-35
Average 90 stars, based on 1 article reviews
rq1 dnase i - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rna isolation kit containing rq1 dnase  (Promega)
90
Promega rna isolation kit containing rq1 dnase
Performance of the multiplex-assay on clinical trial samples. a , b Agreement with previously measured gametocyte densities with single assays, using <t>Pfs25</t> ( a ) and PfMGET ( b ) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 [0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] , y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] and for MG y = 0.8626 [0.7744–0.9507]x + 0.5919 [0.2802–0.9037] , y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] . c Gametocyte prevalence as determined by single or multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c
Rna Isolation Kit Containing Rq1 Dnase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rna+isolation+kit+containing+rq1+dnase/pm40601707-129-28-30
Average 90 stars, based on 1 article reviews
rna isolation kit containing rq1 dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
0.01% rq1 dnase  (Promega)
90
Promega 0.01% rq1 dnase
Performance of the multiplex-assay on clinical trial samples. a , b Agreement with previously measured gametocyte densities with single assays, using <t>Pfs25</t> ( a ) and PfMGET ( b ) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 [0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] , y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] and for MG y = 0.8626 [0.7744–0.9507]x + 0.5919 [0.2802–0.9037] , y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] . c Gametocyte prevalence as determined by single or multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c
0.01% Rq1 Dnase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/0+01++rq1+dnase/pm30936432-272-18-20
Average 90 stars, based on 1 article reviews
0.01% rq1 dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rq1 probes for southern blot and rna in situ dnase  (Promega)
90
Promega rq1 probes for southern blot and rna in situ dnase
Performance of the multiplex-assay on clinical trial samples. a , b Agreement with previously measured gametocyte densities with single assays, using <t>Pfs25</t> ( a ) and PfMGET ( b ) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 [0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] , y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] and for MG y = 0.8626 [0.7744–0.9507]x + 0.5919 [0.2802–0.9037] , y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] . c Gametocyte prevalence as determined by single or multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c
Rq1 Probes For Southern Blot And Rna In Situ Dnase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq1+probes+for+southern+blot+and+rna+in+situ+dnase/10__1016_slash_S0896___6273_ascii40_03_ascii41_00229___0-251-11-21
Average 90 stars, based on 1 article reviews
rq1 probes for southern blot and rna in situ dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rna qualified-dnase treatment rq1 dnase  (Promega)
90
Promega rna qualified-dnase treatment rq1 dnase
Performance of the multiplex-assay on clinical trial samples. a , b Agreement with previously measured gametocyte densities with single assays, using <t>Pfs25</t> ( a ) and PfMGET ( b ) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 [0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] , y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] and for MG y = 0.8626 [0.7744–0.9507]x + 0.5919 [0.2802–0.9037] , y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] . c Gametocyte prevalence as determined by single or multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c
Rna Qualified Dnase Treatment Rq1 Dnase, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rq1+dnase/rq+1+dnase+treated+rna/pmc07337319-108-1-6
Average 90 stars, based on 1 article reviews
rna qualified-dnase treatment rq1 dnase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Performance of the multiplex-assay on clinical trial samples. a , b Agreement with previously measured gametocyte densities with single assays, using Pfs25 ( a ) and PfMGET ( b ) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 [0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] , y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] and for MG y = 0.8626 [0.7744–0.9507]x + 0.5919 [0.2802–0.9037] , y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] . c Gametocyte prevalence as determined by single or multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c

Journal: Malaria Journal

Article Title: A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes

doi: 10.1186/s12936-018-2584-y

Figure Lengend Snippet: Performance of the multiplex-assay on clinical trial samples. a , b Agreement with previously measured gametocyte densities with single assays, using Pfs25 ( a ) and PfMGET ( b ) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 [0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] , y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] and for MG y = 0.8626 [0.7744–0.9507]x + 0.5919 [0.2802–0.9037] , y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] . c Gametocyte prevalence as determined by single or multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c

Article Snippet: Total nucleic acids were used for the intron-containing genes SBP - 1 , Pfg14 - 744 , Pfg14 - 748 , CCp4 and PfMGET while Pfs16 , Pfg27 and Pfs25 required RQ1 DNase I treatment (Promega). cDNA was prepared with the High Capacity cDNA Reverse Transcription Kit (Applied BioSystems) and 2 μL of cDNA was run in the GoTaq qPCR Master Mix (Promega).

Techniques: Multiplex Assay

Primer and probe sequences for qRT-PCR assays, with references for earlier reported methods and primers

Journal: Malaria Journal

Article Title: A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes

doi: 10.1186/s12936-018-2584-y

Figure Lengend Snippet: Primer and probe sequences for qRT-PCR assays, with references for earlier reported methods and primers

Article Snippet: Total nucleic acids were used for the intron-containing genes SBP - 1 , Pfg14 - 744 , Pfg14 - 748 , CCp4 and PfMGET while Pfs16 , Pfg27 and Pfs25 required RQ1 DNase I treatment (Promega). cDNA was prepared with the High Capacity cDNA Reverse Transcription Kit (Applied BioSystems) and 2 μL of cDNA was run in the GoTaq qPCR Master Mix (Promega).

Techniques: